Search
Anavex Life Sciences Corp
AVXLAdd to Watchlist
1.100USD
-0.030-2.65%
Market hours 11/11, 13:06（ET）
101.97MMarket Cap
LossP/E TTM
Anavex Life Sciences Corp (AVXL) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Anavex Life Sciences Corp in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
20.000USD+1580.67%
AVXL Analyst Recommendation Trends
In the current month, AVXL has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AVXL average Analyst price target in the last month is 20.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
1
1
1
1
1
2
2
2
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
2
3
3
AVXL Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ascendis Pharma A/S
ASND
9
13
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, AVXL EPS is projected to reach -0.110 in FY2026Q4, following reported EPS of 0.084 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q3
FY2026Q2
FY2026Q4
FY2027Q1
Forecast
--
-0.11
-0.08
-0.07
-0.11
-0.12
Actual
-0.11
-0.06
0.08
--
--
--
Surprise
--
+41.99%
+205.50%
--
--
--
FAQs
What is Anavex Life Sciences Corp's price target?
Analysts forecast that Anavex Life Sciences Corp's price target is USD 20.00, with the highest forecast at USD 20.00 and the lowest forecast at USD 20.00.
How have Anavex Life Sciences CorpAVXL's recent earnings per share performed?
The market expectation was USD 0.08, while Anavex Life Sciences CorpAVXL's earnings per share (EPS) for the previous quarter was USD -0.06. EPS for the next quarter is expected at USD -0.11.
What is the analyst rating for Anavex Life Sciences Corp?
Based on the ratings of Anavex Life Sciences Corp's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.